LB Pharmaceuticals (LBRX) Stock Price
LB Pharmaceuticals Price
Analysts set a median price target of 45.00 USD, implying 4.6% above the current price. Of 18 analysts, 16 rate the stock a buy — an overall Buy consensus.
LB Pharmaceuticals stock price
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
LB Pharmaceuticals business model & stock analysis
Frequently asked questions about LB Pharmaceuticals
Analysts currently set an average price target of 49.71 USD for the LB Pharmaceuticals stock (median: 45.00 USD), implying +15.6 % versus the latest price. The consensus is based on 18 analyst ratings.
18 analysts currently rate the LB Pharmaceuticals stock: 16 recommend buying, 2 holding and 0 selling.
Converted at the current exchange rate, the LB Pharmaceuticals share trades at 38.99 EUR (43.01 USD).
The revenue cannot currently be calculated for LB Pharmaceuticals.
The expected profit of LB Pharmaceuticals is -138.50 M USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of LB Pharmaceuticals is currently -7.86. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the LB Pharmaceuticals stock.
The P/S cannot be calculated for LB Pharmaceuticals currently.
The Eulerpool Quality Score for LB Pharmaceuticals is 2/10.
The ISIN of LB Pharmaceuticals is US50180M1080. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The ticker of LB Pharmaceuticals is LBRX. The ticker symbol is used to trade LB Pharmaceuticals shares on the stock exchange.
LB Pharmaceuticals stock
LB Pharmaceuticals Peer Group
All fundamentals and in-depth analysis of LB Pharmaceuticals
Our stock analysis for LB Pharmaceuticals stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of LB Pharmaceuticals. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.